Stomach Cancer Trial, Recruiting NCT06881511 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT06881511
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with autoimmune gastritis at the Second Affiliated Hospital of Zhejiang University School of Medicine, using the specific diagnostic criteria defined by the trial research team
  • People whose gastrin levels (a hormone produced in the stomach) are higher than 300 pmol/L, or who have a history of a type of small stomach tumour (type 1 gastric neuroendocrine tumour) or early stomach cancer that was treated with a procedure called endoscopic submucosal dissection (ESD)
  • People aged between 18 and 80 years
  • People who have signed a consent form agreeing to take part in the clinical trial

Who may not be able to join:

  • People who are allergic to betaine hydrochloride (a supplement sometimes used to support stomach acid levels)
  • People who have peptic ulcers (sores in the lining of the stomach or small intestine)
  • People whose elevated gastrin levels are caused by a condition other than autoimmune gastritis, such as a gastrinoma (a type of tumour that produces excess gastrin)
  • People who are unwilling to sign the trial consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86-571-8778-3540

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
3 January 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Serum Gastrin Levels; Gastrointestinal Symptom Scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov